EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants 17.01.2025 / 22:50 CET/CEST The issuer is solely ...

(Nasdaq: ACON), a company specializing in cutting-edge healthcare technology, saw its stock price surge by +6.44%, reaching $0.0479 during Friday’s premarket trading session. The jump follows the ...

In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating -67.49% over the last five trades and -57.14% over the past 30 trades. This represents a notable shift from ...

Aclarion, Inc. (ACON) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Aclarion, Inc. (NASDAQ: ACON) recently disclosed the outcomes of its 2024 Annual Meeting of Stockholders in a Form 8-K filing with the Securities and Exchange Commission. The meeting, which took place ...

Aclarion, Inc. (NASDAQ: ACON) has announced the termination of the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The termination notice was given on January 3, 2025, and ...

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...